Biotechnology Stocks II Performance Guide: Lexicon Pharmaceuticals, Inc. (LXRX)
LXRX has no dividends.
Table and Chart of LXRX Performance
See what a $1,000 investment in LXRX is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| LXRX Returns | |
|---|---|
| Start Date | May-30-2014 |
| Start Price | $9.24 |
| End Date | May-17-2024 |
| End Price | $1.77 |
| # Prices | 121 |
| Min Date | Nov-30-2023 |
| Min Price | $1.06 |
| Max Date | Sep-30-2016 |
| Max Price | $18.07 |
| Total Return | -80.84% |
| Annualized Return | -15.12% |
| Current Value of $1,000 Purchase | $192 |
| Number Returns | 7,260 |
| Average Return | -32.53% |
| Number Profitable Returns | 1,642 |
| Percent Profitable Returns | 22.62% |
| Number Unprofitable Returns | 5,618 |
| Percent Unprofitable Returns | 77.38% |
| Profitable to Unprofitable Returns Ratio | 0.29 |
| LXRX Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $639,841,000 |
| Beta | 1.377 | Price to Sales | 402.90 |
| Earnings per Share | $-0.8300 |
| PE Ratio | None |
| PE to Growth Ratio | -0.14 |
| Price to Book | 5.21 |
| PRICE DATA | |
| 52 Week High | $3.73 |
| 52 Week Low | $0.92 |
| Analyst Target Price | $5.25 |
| 50-Day Moving Average | $1.995 |
| 200-Day Moving Average | $1.667 |
| FINANCIAL DATA | |
| Revenue per Share | $0.01 |
| Revenue | $2,310,000 |
| Profit Margin | 0% |
| Return on Equity | -102.7% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
LXRX Compare Returns with S&P 500
LXRX Trendline Chart
LXRX Moving Average Chart
LXRX Stock Return Map - See Patterns of Gains and Losses
LXRX Stock Returns/Purchase Dates